Akari Therapeutics Plc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Akari Therapeutics Plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • Akari Therapeutics Plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.08M, a 65% increase year-over-year.
  • Akari Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2023 was -$12.8M, a 2.01% increase from 2022.
  • Akari Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2022 was -$13.1M, a 24.9% increase from 2021.
  • Akari Therapeutics Plc annual Net Income (Loss) Attributable to Parent for 2021 was -$17.4M, a 2.01% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.08M +$3.87M +65% Apr 1, 2024 Jun 30, 2024 8-K 2024-09-06
Q1 2024 -$5.57M -$6.57M -656% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-19
Q2 2023 -$5.94M -$264K -4.65% Apr 1, 2023 Jun 30, 2023 8-K 2024-09-06
Q1 2023 $1M Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-19
Q2 2022 -$5.68M -$1.33M -30.7% Apr 1, 2022 Jun 30, 2022 6-K 2022-09-27
Q2 2021 -$4.35M +$3.09M +41.6% Apr 1, 2021 Jun 30, 2021 6-K 2022-09-27
Q4 2020 -$17.1M -$6.81M +$1.02M +13% Oct 1, 2020 Dec 31, 2020 20-F 2023-05-01
Q3 2020 -$18.1M $913K +$3.8M Jul 1, 2020 Sep 30, 2020 20-F 2021-04-21
Q2 2020 -$21.9M -$7.44M -$1.49M -25.1% Apr 1, 2020 Jun 30, 2020 6-K 2021-09-22
Q1 2020 -$20.4M -$3.75M -$3.56M -1908% Jan 1, 2020 Mar 31, 2020 20-F 2021-04-21
Q4 2019 -$16.8M -$7.83M Oct 1, 2019 Dec 31, 2019 20-F 2022-05-16
Q3 2019 -$2.88M Jul 1, 2019 Sep 30, 2019 20-F 2021-04-21
Q2 2019 -$5.95M +$2.07M +25.9% Apr 1, 2019 Jun 30, 2019 20-F 2021-04-21
Q1 2019 -$187K Jan 1, 2019 Mar 31, 2019 20-F 2021-04-21
Q2 2018 -$8.02M -$7.7M -2407% Apr 1, 2018 Jun 30, 2018 6-K 2019-08-29
Q2 2017 -$320K +$6.13M +95% Apr 1, 2017 Jun 30, 2017 6-K 2018-09-27
Q2 2016 -$51.7M -$6.45M -$5.11M -381% Apr 1, 2016 Jun 30, 2016 6-K 2017-08-10
Q1 2016 -$46.6M -$2.99M -$1.29M -75.9% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$45.3M $6.46M +$4.21M +188% Oct 1, 2015 Dec 31, 2015 20-F 2018-07-18
Q3 2015 -$49.5M -$48.7M -$48.5M -21742% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-23
Q2 2015 -$1.02M -$1.34M +$888K +39.8% Apr 1, 2015 Jun 30, 2015 6-K/A 2017-04-14
Q1 2015 -$1.9M -$1.7M +$43.2K +2.48% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$1.95M $2.24M Oct 1, 2014 Dec 31, 2014 20-F 2017-03-31
Q3 2014 -$223K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$2.23M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$1.74M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.